AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,678.00p
   
  • Change Today:
    -64.00p
  • 52 Week High: 12,294.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.21m
  • Volume: 1,276,799
  • Market Cap: £165,531m
  • RiskGrade: 123

AstraZeneca Overview

A world-leading pharmaceutical group, AstraZeneca was created in 1999 via the merger of Sweden's Astra and the UK's Zeneca, which had been demerged from chemicals group ICI in 1993. About half of its total sales are generated from the US, with over a third of revenues coming from its gastrointestinal treatments such as Prilosec (Losec) and Nexium.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

AstraZeneca Financials

Latest F'cast
Div Yield 2.2% 0.0%
Div Cover 1.3 2.6
Op Mrgn 17.9% 30.8%
ROCE 60.1%  
Latest F'cast
P/E 35.1 16.4
PEG 0.4 0.2
Pr/Revenue 4.6 3.2
Pr/Book 5.3  
Latest F'cast
Revenue 3.3% -12.4%
PBT 175.8% 79.4%
EPS 81.1% 112.7%
DPS n/a -32.5%

AstraZeneca Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 24,384.00 1,548.00 103.00¢ 93.2 n/a -39% 280.00¢ 2.9%
31-Dec-20 26,617.00 3,916.00 244.00¢ 37.9 0.3 +137% 280.00¢ 3.0%
31-Dec-21 37,417.00 (265.00) 8.00¢ 1,369.4 n/a -97% 287.00¢ 2.6%
31-Dec-22 44,351.00 2,501.00 212.00¢ 66.8 0.0 +2,550% 290.00¢ 2.0%
31-Dec-23 45,811.00 6,899.00 384.00¢ 34.8 0.4 +81% 290.00¢ 2.2%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

AstraZeneca Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 50,652.78 15,622.29 648.16p 16.5 0.1 +113% 246.98p 0.0%
31-Dec-25 54,503.57 17,859.33 735.10p 14.5 1.1 +13% 258.56p 0.0%
31-Dec-26 57,326.46 19,166.55 801.86p 13.3 1.5 +9% 264.15p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

AstraZeneca Company Announcements

Ultomiris approved in the US for NMOSD 25-Mar-2024 07:00 RNS
AstraZeneca to acquire Fusion 19-Mar-2024 07:00 RNS
AstraZeneca to acquire Amolyt 14-Mar-2024 07:00 RNS

Latest AstraZeneca Director Deals

Traded Action Notifier PriceAmountValue
08-Mar-24 Transfer From Pascal Soriot 0.000p 105,238 £0.00
20-Feb-24 Transfer From Pascal Soriot 0.000p 12,345 £0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,678.00p
Change Today -64.00p
% Change -0.60 %
52 Week High 12,294.00
52 Week Low 9,501.00
Volume 1,276,799
Shares Issued 1,550.21m
Market Cap £165,531m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.33% below the market average88.33% below the market average88.33% below the market average88.33% below the market average88.33% below the market average
92.59% below the sector average92.59% below the sector average92.59% below the sector average92.59% below the sector average92.59% below the sector average
Price Trend
12.34% above the market average12.34% above the market average12.34% above the market average12.34% above the market average12.34% above the market average
64.91% above the sector average64.91% above the sector average64.91% above the sector average64.91% above the sector average64.91% above the sector average
Income
85.1% below the market average85.1% below the market average85.1% below the market average85.1% below the market average85.1% below the market average
71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average71.43% below the sector average
Growth
80.99% above the market average80.99% above the market average80.99% above the market average80.99% above the market average80.99% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average

What The Brokers Say

Strong Buy 7
Buy 13
Neutral 6
Sell 0
Strong Sell 2
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 28-Mar-2024

Time Volume / Share Price
16:58 10,298 @ 10,757.95p
16:39 600 @ 10,678.00p
16:37 1,835 @ 10,678.00p
16:35 600 @ 10,678.00p
16:35 400 @ 10,678.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page